Sei Investments CO Enanta Pharmaceuticals Inc Transaction History

Sei Investments CO

  • $75.3 Billion
  • Q4 2024

A detailed history of Sei Investments CO transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 72,789 shares of ENTA stock, worth $566,298. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,789
Previous 72,925 0.19%
Holding current value
$566,298
Previous $756,000 44.71%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$5.75 - $12.99 $782 - $1,766
-136 Reduced 0.19%
72,789 $418,000
Q2 2024

Aug 13, 2024
SELL
$11.43 - $17.02 $174,078 - $259,214
-15,230 Reduced 17.28%
72,925 $945,000
Q4 2023

Feb 14, 2024
BUY
$8.18 - $10.78 $329,457 - $434,175
40,276 Added 84.12%
88,155 $829,000
Q3 2023

Nov 14, 2023
BUY
$11.09 - $22.13 $530,978 - $1.06 Million
47,879 New
47,879 $534,000
Q2 2022

Aug 15, 2022
SELL
$38.13 - $76.93 $176,465 - $356,032
-4,628 Reduced 24.92%
13,942 $659,000
Q1 2022

May 13, 2022
SELL
$56.06 - $74.11 $514,967 - $680,774
-9,186 Reduced 33.1%
18,570 $1.32 Million
Q4 2021

Feb 14, 2022
BUY
$60.19 - $97.37 $492,233 - $796,291
8,178 Added 41.77%
27,756 $2.06 Million
Q3 2021

Nov 12, 2021
BUY
$41.02 - $58.65 $123 - $175
3 Added 0.02%
19,578 $1.1 Million
Q2 2021

Aug 06, 2021
SELL
$43.76 - $53.11 $10,589 - $12,852
-242 Reduced 1.22%
19,575 $841,000
Q1 2021

May 12, 2021
SELL
$41.69 - $54.95 $6,170 - $8,132
-148 Reduced 0.74%
19,817 $943,000
Q4 2020

Feb 08, 2021
SELL
$41.16 - $47.47 $41,571 - $47,944
-1,010 Reduced 4.82%
19,965 $815,000
Q3 2020

Dec 04, 2020
SELL
$43.36 - $53.53 $346 - $428
-8 Reduced 0.04%
20,975 $937,000
Q3 2020

Nov 06, 2020
BUY
$43.36 - $53.53 $76,356 - $94,266
1,761 Added 9.16%
20,983 $937,000
Q2 2020

Aug 17, 2020
SELL
$46.37 - $57.58 $74,099 - $92,012
-1,598 Reduced 7.68%
19,222 $958,000
Q2 2020

Aug 11, 2020
BUY
$46.37 - $57.58 $159,605 - $198,190
3,442 Added 19.81%
20,820 $1.28 Million
Q1 2020

May 14, 2020
SELL
$40.22 - $62.0 $131,157 - $202,182
-3,261 Reduced 15.8%
17,378 $894,000
Q1 2019

May 15, 2019
BUY
$69.08 - $105.66 $323,225 - $494,383
4,679 Added 29.32%
20,639 $1.97 Million
Q4 2018

Feb 13, 2019
BUY
$65.41 - $84.65 $15,175 - $19,638
232 Added 1.48%
15,960 $1.33 Million
Q3 2018

Nov 08, 2018
BUY
$85.46 - $126.37 $1.15 Million - $1.7 Million
13,460 Added 593.47%
15,728 $1.32 Million
Q2 2018

Aug 03, 2018
BUY
$81.85 - $120.51 $28,320 - $41,696
346 Added 18.0%
2,268 $263,000
Q1 2018

May 11, 2018
BUY
$57.91 - $92.15 $111,129 - $176,835
1,919 Added 63966.67%
1,922 $156,000
Q4 2017

Feb 08, 2018
BUY
$45.65 - $59.37 $136 - $178
3
3 $0

Others Institutions Holding ENTA

# of Institutions
108
Shares Held
19.7M
Call Options Held
9.7K
Put Options Held
12.4K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $161M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email